Press Releases

  • VolitionRx Limited Announces Closing of Public Offering of Common Stock

  • VolitionRx Limited Announces Pricing of Public Offering of Common Stock

  • VolitionRx Limited Announces Proposed Public Offering of Common Stock

  • VolitionRx to Attend Several Conferences in September

  • Volition's Nu.Q Triage Colorectal Cancer Screening Test Expected to Reduce Colonoscopy Referral by 25 Percent

  • VolitionRx Schedules Product Launch Update Conference Call for Tuesday, September 6, 2016 at 8:30 am ET

  • VolitionRx Announces Second Quarter 2016 Financial Results and Business Update

  • VolitionRx Schedules Second Quarter 2016 Earnings Conference Call and Business Update for Thursday, August 11, 2016 at 8:30am ET

  • VolitionRx Engages Edison Advisors as Investor Relations Counsel

  • VolitionRx Granted Fourth U.S. Patent

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus